A planar Josephson junction with a normal metal attached on its top surface will form a hollow nanowire structure due to its three dimensional nature. In such hollow nanowire structure, the magnetic flux induced by a small magnetic field (about 0.01T) will tune the system into topologically non-trivial phase and therefore two Majorana zero-modes will form at the ends of the nanowire. Through tuning the chemical potential of the normal metal, the topologically non-trivial phase can be obtained for almost all energy within the band. Furthermore, the system can be conveniently tuned between the topologically trivial and non-trivial phases via the phase difference between the superconductors. Such device, manipulable through flux, can be conveniently fabricated into desired 2D networks. Finally, we also propose a cross-shaped junction realizing the braiding of Majorana zero-modes through manipulating the phase differences.
The low-energy Andreev bound states (ABSs) mixing with the Majorana zero modes (MZMs) may destroy the non-Abelian braiding statistics of the MZMs. We numerically studied the braiding properties of MZMs when an ABS is present. Numerical simulation results support the argument that the ABS can be regarded as a pair of weakly coupled MZMs. The non-Abelian braiding properties of MZMs exhibit oscillation behaviour with respect to the braiding time if the ABSrelated dynamic phase is present. Remarkably, such dynamic phase can be eliminated by tuning the magnetic field or gate voltage. In this way, the non-Abelian braiding statistics independent of the braiding time retrieves so that the topological quantum computation could still be robust even when the ABS is engaged.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.